Stay updated with breaking news from Dunbar Car Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
10.11.2022 - INB-100 continued to demonstrate durable morphologic complete responses in the Phase 1 clinical trial in patients with leukemia; on track to announce additional data at upcoming ASH annual meeting.Partnered with the Dunbar CAR T-Cell Program at the ...
INB-100 continued to demonstrate durable morphologic complete responses in the Phase 1 clinical trial in patients with leukemia; on track to announce...
IN8bio (NASDAQ:INAB) chief financial officer Patrick McCall takes Proactive's Stephen Gunnion through the clinical-stage biopharmaceutical...
Agreement provides exclusive access to state-of-the-art GMP manufacturing suites to support Phase 2 clinical studiesPotential to expand the agreement to...
IN8bio Partners with the Dunbar CAR T-Cell Program at the University of Louisville as the Manufacturing Center for INB-400 - read this article along with other careers information, tips and advice on BioSpace